{"brief_title": "A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)", "brief_summary": "The purpose of this study is to evaluate the lipid lowering effects of an investigational drug in patients with hypercholesterolemia (high cholesterol).", "detailed_description": "The duration of treatment is 4 months.", "condition": ["Hypercholesterolemia"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0653A, ezetimibe (+) simvastatin", "Comparators: simvastatin and ezetimibe"], "criteria": "Inclusion Criteria: - High cholesterol Exclusion Criteria: - Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "80 Years", "healthy_volunteers": "No", "keyword": "Primary hypercholesterolemia", "mesh_term": ["Hypercholesterolemia", "Ezetimibe", "Simvastatin", "Ezetimibe, Simvastatin Drug Combination"], "id": "NCT00092651"}